FdaApplication
ANDA 217215
Identifiers
- fda_app_no: ANDA217215
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA LTD |
| application_type | ANDA |
| approval_date | 2024-08-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DAPTOMYCIN | DAPTOMYCIN | 500MG/VIAL | POWDER;INTRAVENOUS |
1 product